MD, PhD
Deputy Director of the Department of Oncology, Doctoral Supervisor
Tongji University School of Medicine
In this special edition of Lung Cancer Considered, three esteemed oncologists and lung cancer experts explore the issues facing clinicians and researchers treating Chinese patients with NSCLC with EGFR mutations.